Detalles de la búsqueda
1.
Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer.
Br J Cancer
; 125(9): 1217-1225, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480096
2.
[A Case of Triple Cancer-A Patient Developed Malignant Lymphoma and Colon Cancer, during Breast Cancer Treatment].
Gan To Kagaku Ryoho
; 48(11): 1397-1399, 2021 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-34795134
3.
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study.
Br J Cancer
; 122(12): 1747-1753, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32238920
4.
Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancer.
Jpn J Clin Oncol
; 50(8): 873-881, 2020 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32463090
5.
Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study.
Breast Cancer Res Treat
; 176(3): 631-635, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31115845
6.
Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.
BMC Cancer
; 17(1): 773, 2017 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29149882
7.
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 17(1): 90-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26617202
8.
Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer.
Surg Today
; 46(7): 821-6, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467559
9.
Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis.
Breast Cancer Res Treat
; 149(1): 277-84, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25528021
10.
Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial.
Breast Cancer Res Treat
; 148(2): 337-43, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25318924
11.
Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.
Breast Cancer Res Treat
; 147(1): 103-12, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25106661
12.
Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer.
BMC Cancer
; 13: 239, 2013 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-23679192
13.
Effect of early dose increase of evocalcet for intractable hypercalcemia caused by parathyroid carcinoma.
Endocrinol Diabetes Metab Case Rep
; 2023(1)2023 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36602916
14.
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.
J Clin Oncol
; 41(18): 3329-3338, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37079878
15.
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
Lancet
; 377(9762): 321-31, 2011 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21247627
16.
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).
Breast Cancer Res Treat
; 133(1): 227-36, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234519
17.
Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results.
Breast Cancer Res Treat
; 133(2): 685-93, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22307266
18.
Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03.
Breast Cancer Res Treat
; 127(1): 143-52, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21347648
19.
Spontaneous regression of pulmonary metastases from a malignant phyllodes tumor.
Jpn J Clin Oncol
; 41(7): 915-7, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21527411
20.
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2.
Case Rep Oncol
; 14(3): 1645-1651, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35082620